Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04460027 · ClinicalTrials.gov registry record · Phase 1
W-SUDs for COVID-19
A Phase 1 study, sponsored by Woebot Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 180
- Enrollment target
NCT04460027 is a Phase 1 study that has completed, run by Woebot Health. The registered enrollment target is 180 participants.
The verdict
NCT04460027, a Phase 1 study, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce substance use relative to a wait list control condition, and explore between group differences on quality of life indices as well as retention and engagement during COVID-19.
Interventions
- OTHER Woebot Substance Use Disorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2020-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04460027
The ClinicalTrials.gov registry entry for NCT04460027 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woebot Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Woebot Substance Use Disorder is the first listed.
NCT04460027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04460027 about?
NCT04460027 is a clinical study titled "W-SUDs for COVID-19". The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce subs...
What is the current status of trial NCT04460027?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 180 participants. The study started on 2020-06-22. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT04460027?
The interventions under investigation include: Woebot Substance Use Disorder (OTHER).
Who is sponsoring clinical trial NCT04460027?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.